摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2-bromo-4-fluoro-phenyl)-carbamic acid tert-butyl ester | 384793-18-4

中文名称
——
中文别名
——
英文名称
(2-bromo-4-fluoro-phenyl)-carbamic acid tert-butyl ester
英文别名
(2-bromo-4-fluorophenyl)-carbamic acid tert-butyl ester;(2-bromo-4-fluorophenyl)carbamic acid tert-butyl ester;tert-butyl N-(2-bromo-4-fluorophenyl)carbamate;tert-butyl (2-bromo-4-fluorophenyl)carbamate
(2-bromo-4-fluoro-phenyl)-carbamic acid tert-butyl ester化学式
CAS
384793-18-4
化学式
C11H13BrFNO2
mdl
——
分子量
290.132
InChiKey
KZKKPWHZRLYHGX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    38-39 °C
  • 沸点:
    275.0±30.0 °C(Predicted)
  • 密度:
    1.459±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    16
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    38.3
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (2-bromo-4-fluoro-phenyl)-carbamic acid tert-butyl ester偶氮二异丁腈三(三甲基硅基)硅烷 、 sodium hydride 作用下, 以 N,N-二甲基甲酰胺甲苯 为溶剂, 反应 36.0h, 生成 tert-butyl 3-chloromethyl-5-fluoro-2,3-dihydroindole-1-carbox-ylate
    参考文献:
    名称:
    Probing cytochrome P450 (CYP) bioactivation with chloromethylindoline bioprecursors derived from the duocarmycin family of compounds
    摘要:
    DOI:
    10.1016/j.bmc.2021.116167
  • 作为产物:
    参考文献:
    名称:
    Indole Synthesis by Controlled Carbolithiation of o-Aminostyrenes
    摘要:
    An effective synthesis of the functionalized indole ring system has been developed from substituted o-aminostyrene starting material. Our methodology involves a novel cascade reaction sequence of alkyllithium addition to the styrene double bond and subsequent trapping of the intermediate organolithium with a suitable electrophile, followed by an in situ ring closure and dehydration to generate the indole ring. This new reaction sequence allows for the introduction of molecular diversity at all positions on the indole scaffold. The procedure was shown to be successful with a range of both C and N substituents on the o-aminostyrenes. The reaction sequence was tolerant to the reactivity range of alkyllithiums such as tert-, sec-, and n-butyllithium. The electrophiles used were DMF, which generated indole products with C-2 unsubstituted, and nitriles, which incorporated the nitrile substituent at C-2. The o-aminostyrene starting materials were generated by a Pd-catalyzed cross-coupling reaction of a vinyl boronic acid equivalent with the readily available substituted o-bromoanilines.
    DOI:
    10.1021/jo048723e
点击查看最新优质反应信息

文献信息

  • Nucleus- and side-chain fluorinated 3-substituted indoles by a suitable combination of organometallic and radical chemistry
    作者:Francesca Bellezza、Antonio Cipiciani、Renzo Ruzziconi、Sara Spizzichino
    DOI:10.1016/j.jfluchem.2007.09.003
    日期:2008.2
    o-bromoarylcarbamate and reductive radical cyclization of the product with tributyltin hydride/AIBN. 3-Methyleneindolines, as valuable, versatile intermediates, can be transformed into highly functionalized 3-substituted indoles by ene-type reactions using different enophiles. Thus, fluoro-, trifluoromethyl- and trifluoromethoxy-substituted diethyl 2-hydroxy-2-[(1H-indol-3-yl)methyl]malonates, ethyl 2-hydroxy-3
    使用四步程序制备了区域选择性的,三甲基和三甲氧基取代的3-亚甲基二氢吲哚,所述方法包括化/ Boc保护的苯胺属化/化,所得邻代芳基氨基甲酸酯的N-炔丙基化以及产物的还原自由基环化反应。氢化三丁基锡/ AIBN。3-亚甲基二氢吲哚,作为有价值的通用中间体,可以使用不同的亲和剂通过烯类反应转化为高度官能化的3-取代的吲哚。因此,-,三甲基-和三甲氧基取代的2-乙基-2-羟基-2-[((1 H-吲哚-3-基)甲基]丙二酸二乙酯,2-羟基-3-(1 H-吲哚-3-基)乙基丙酸酯和2-羟基-3-(1 H通过简单地加热相应的3-亚甲基吲哚啉-1-羧酸叔丁酯与等摩尔量的酮丁二酸二乙酯乙二醛乙酯和3,3,3-乙基吲哚-3-基)-2-三甲基丙酸酯,以77-86%的产率获得。在无溶剂的情况下,分别于100°C和3-三丙酮酸0.5–4小时。
  • [EN] FUSED MORPHOLINOPYRIMIDINES AND METHODS OF USE THEREOF<br/>[FR] MORPHOLINOPYRIMIDINES FUSIONNÉES ET PROCÉDÉS D'UTILISATION DE CES DERNIÈRES
    申请人:FORUM PHARMACEUTICALS INC
    公开号:WO2015066697A1
    公开(公告)日:2015-05-07
    The present invention relates to Fused Morpholinopyrimidines, pharmaceutical compositions comprising an effective amount of a Fused Morpholinopyrimidine and methods for using a Fused Morpholinopyrimidine in the treatment of a neurodegenerative disease, comprising administering to a subject in need thereof an effective amount of a Fused Morpholinopyrimidine.
    本发明涉及融合吗啉嘧啶类化合物,包括有效量的融合吗啉嘧啶的药物组合物以及使用融合吗啉嘧啶治疗神经退行性疾病的方法,包括向需要的受试者施用有效量的融合吗啉嘧啶
  • New Organolithium Addition Methodology to Diversely Functionalized Indoles
    作者:Claire M. Coleman、Donal F. O'Shea
    DOI:10.1021/ja034283h
    日期:2003.4.1
    A novel synthetic approach to diversely functionalized indoles is described. Boc-protected ortho-aminostyrenes undergo an alkyllithium addition reaction, thereby generating a lithiated intermediate, which upon reaction with specific electrophiles sets up a cascade reaction process between the reacted electrophile and ortho-amino substituent, facilitating an in situ ring closure, followed by dehydration
    描述了一种用于不同功能化吲哚的新型合成方法。Boc 保护的邻苯乙烯发生烷基加成反应,从而生成化中间体,该中间体与特定亲电试剂反应后,在反应的亲电试剂和邻基取代基之间建立级联反应过程,促进原位闭环,然后脱,生成吲哚环系统。这种方法可以通过合成一系列 3,5-、1,3,5- 和 2,3,5- 取代的吲哚来证明。
  • Synthesis of new indole-based bisphosphonates and evaluation of their chelating ability in PE/CA-PJ15 cells
    作者:Carlo A. Palmerini、Francesco Tartacca、Michela Mazzoni、Letizia Granieri、Laura Goracci、Angela Scrascia、Susan Lepri
    DOI:10.1016/j.ejmech.2015.08.019
    日期:2015.9
    oncology. These compounds have high affinity for calcium ions (Ca2+) and therefore target bone mineral, where they appear to be internalized selectively by bone-resorbing osteoclasts and inhibit osteoclast function. They are extensively used in healthcare, however they are affected by severe side effects; pharmacological properties of bisphosphonates depend on their molecular structure, which is frequently
    双膦酸盐是最重要的一类抗吸收剂,可用于抗破骨细胞介导的骨质流失,最近在肿瘤学中也是如此。这些化合物对钙离子(Ca 2+)具有高亲和力,因此靶向骨矿物质,在这些地方矿物质似乎被骨吸收破骨细胞选择性内化并抑制破骨细胞功能。它们广泛用于医疗保健中,但是会受到严重副作用的影响。双膦酸酯的药理特性取决于其分子结构,这通常是肠道吸收差和分布低的原因。在这项工作中,我们合成了六种具有可变取代的吲哚部分的新型双膦酸酯化合物,以评估它们在PE / CA-PJ15细胞中的细胞外和细胞内螯合能力。初步的在片和体外ADME研究还进行和结果表明,吲哚部分在细胞渗透性和代谢性质中起重要作用。
  • Solvent-free, uncatalyzed asymmetric “ene” reactions of N-tert-butylsulfinyl-3,3,3-trifluoroacetaldimines: a general approach to enantiomerically pure α-(trifluoromethyl)tryptamines
    作者:Giuseppe Mazzeo、Giovanna Longhi、Sergio Abbate、Martina Palomba、Luana Bagnoli、Francesca Marini、Claudio Santi、Jianlin Han、Vadim A. Soloshonok、Emilio Di Crescenzo、Renzo Ruzziconi
    DOI:10.1039/c7ob00670e
    日期:——
    A novel approach to regioselectively substituted and stereoselectively α-trifluoromethylated tryptamines is reported based on the ene reaction of Boc-protected 3-methyleneindolines with optically pure (R)- or (S)-tert-butanesulfinyltrifluoroacetaldimine. Boc- and sulfinylamido-protected α-trifluoromethyltryptamines are obtained in 60–70% yield and 85/15 dr by just heating equimolar amounts of the two
    基于Boc保护的3-亚甲基二氢吲哚与光学纯(R)-或(S)-叔胺的烯键反应,报道了一种新的区域选择性取代和立体选择性α-三甲基化色胺的方法-丁烷亚磺酰基三乙二胺。仅在80-90°C下将等摩尔量的两个反应伙伴在无溶剂下加热2–3 h,即可获得Boc和亚磺酰基保护的α-三甲基色胺,产率为60-70%,dr为85/15 dr。基α-碳的绝对构型已基于振动圆二色性(VCD)光谱分析确定。可以化学选择性地除去两个保护基团,从而允许将烯产物进一步区域和立体选择性地修饰成各种生物学上感兴趣的化合物。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫